Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
J. Walter Thompson last week won creative duties outside the U.S. on an unnamed new incontinence drug to be co-marketed by Boehringer Ingelheim and Eli Lilly & Co., sources said. The other finalists for the estimated $25 million assignment were Omnicom’s BBDO in Dusseldorf, Germany; IPG’s Foote Cone & Belding in New York; and Havas’ Euro RSCG Life in London, said sources. JWT’s London office will likely manage the account.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in